Yo no tengo claro que el cortisol se vea afectado durante el ciclo con esteroides y si lo es no hasta el punto de tener que controlarlo, de echo es afectado muy poco segun los estudios que lei o nada y el tomar cytadren lo que hara es bajarlo mas, y el cortisol por debajo de los niveles fisiologicos no es tampoco algo bueno , el cortisol tiene su funcion en el cuerpo tambien
Os dejo unos estudios donde salen un grupo de athletas usando esteroides y miden los valores del cortisol.
Estudio 1
Physiological responses to resistance-exercise in athletes self-administering anabolic steroids.
Rozenek R, Rahe CH, Kohl HH, Marple DN, Wilson GD, Stone MH.
Department of Physical Education, California State University Long Beach.
Endocrine and metabolic responses to resistance exercise were compared in 5 athletes self-administering (SL) anabolic steroids and 8 athletes (L) not using these compounds. Exercise consisted of 5 sets of 10 repetitions in the squat and quarter squat. Blood samples were collected before (pre) and immediately after (post) exercise, and following 30 minutes of recovery (post-30). Except for significantly lower lactate concentrations in SL (p less than 0.015) at post-30, the responses to exercise and recovery were similar in both groups. Significantly higher hematocrits (p less than 0.0001), total androgen concentrations (p less than 0.0001), and androgen/cortisol ratios (p less than 0.0001) were observed in the SL group across all time periods. Plasma androgen concentrations increased about 22% in SL following exercise, even though plasma LH concentrations were significantly lower (p less than 0.0001) than in L. Plasma ACTH and cortisol concentrations were not significantly affected. Both groups displayed similar endocrine and metabolic responses to an acute bout of resistance exercise. The higher androgen/cortisol ratios and lower plasma lactate concentrations during recovery are two potential factors which may help explain the lower subjective level of fatigue following training sessions often reported by individuals who use anabolic steroids.
Estudio 2
Response of serum hormones to androgen administration in power athletes.
Alen M, Reinila M, Vihko R.
Endocrine effects of self-administration of high doses of anabolic steroids and testosterone were investigated in five power athletes during 26 wk of training, and for the following 12-16 wk after drug withdrawal. After 26 wk of anabolic steroid and testosterone administration, serum testosterone concentrations had increased 2.3-fold. This was associated with increased concentrations of serum estradiol, which rose 7-fold to values (0.48 nmol X 1(-1) typical for females. There was a major decrease in serum FSH and LH concentrations, but they returned to control levels following drug withdrawal. However, serum testosterone concentrations stayed at low levels (9 nmol X 1(-1) ) during this follow-up period, indicating long-lasting impairment of testicular endocrine function. Serum ACTH concentrations were also decreased during steroid administration, possibly due to a corticoid-like effect of some of the anabolic steroids taken in high doses. However, no changes were seen in serum cortisol. The only consistent change in the control group was an increase in serum LH concentrations during the most intensive training, suggesting that a decreasing tendency of serum testosterone was compensated for by augmented LH secretion.
Estudio 3
Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man.
Ruokonen A, Alen M, Bolton N, Vihko R.
The influence of high doses of testosterone and anabolic steroids on testicular endocrine function and on circulating steroid binding proteins, sex hormone binding globulin (SHBG) and cortisol binding globulin (CBG), were investigated in power athletes for 26 weeks of steroid self-administration and for the following 16 weeks after drug withdrawal. Serum testosterone and androstenedione concentrations increased (P less than 0.05) but pregnenolone, 17-hydroxypregnenolone, dehydroepiandrosterone, 5-androstene-3 beta, 17 beta-diol, progesterone and 17-hydroxyprogesterone concentrations strongly decreased (P less than 0.001) during steroid administration. Serum pregnenolone, 17-hydroxypregnenolone and dehydroepiandrosterone sulphate concentrations followed the changes of the corresponding unconjugated steroids but 5-androstene-3 beta, 17 beta-diol and testosterone sulphate concentrations remained unchanged during the follow-up time. During drug administration SHBG concentrations decreased by about 80 to 90% and remained low even for the 16 weeks following steroid withdrawal. Steroid administration had no influence on serum CBG concentrations. In conclusion, self-administration of testosterone and anabolic steroids soon led to impairment of testicular endocrine function which was characterized by low concentrations of testosterone precursors, high ratios of testosterone to its precursor steroids and low SHBG concentrations. Decreased concentrations of SHBG and testicular steroids were still partly evident during the 16 weeks after drug withdrawal. The depressed circulating levels of dehydroepiandrosterone and its sulphate may indicate that the androgenic-anabolic steroids also suppress adrenal androgen production.